<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010081425">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Tornyigah, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">d'Almeida, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Escriou, G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Viwami, F.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Fievet, Nadine</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Luty, Adrian</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Massougbodji, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nielsen, M. A.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Deloron, Philippe</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Tuikue Ndam, Nicaise</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Plasmodium falciparum VAR2CSA-specific IgG subclass responses reflect protection against low birth weight and pregnancy-associated malaria</title>
        <secondary-title>Frontiers in Immunology</secondary-title>
      </titles>
      <pages>610305 [8 p.]</pages>
      <keywords>
        <keyword>pregnancy</keyword>
        <keyword>malaria</keyword>
        <keyword>VAR2CSA</keyword>
        <keyword>IgG subclasses</keyword>
        <keyword>IgG3</keyword>
        <keyword>IgG4</keyword>
      </keywords>
      <dates>
        <year>2021</year>
      </dates>
      <call-num>fdi:010081425</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Frontiers in Immunology</full-title>
      </periodical>
      <isbn>1664-3224</isbn>
      <accession-num>ISI:000647107800001</accession-num>
      <electronic-resource-num>10.3389/fimmu.2021.610305</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010081425</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2021-06/010081425.pdf</url>
        </pdf-urls>
      </urls>
      <volume>12</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Sequestration of Plasmodium falciparum-infected erythrocytes expressing the VAR2CSA antigen in the placenta results in poor pregnancy outcomes, including low birth weight and maternal anemia. Antigen-specific antibody-mediated immunity is acquired during successive pregnancies. Thus, evaluating VAR2CSA-specific IgG profiles among pregnant women will increase knowledge on the immunological mechanisms associated with protection, and help in the development of VAR2CSA-based placental malaria vaccines. Using the PAMVAC candidate vaccine antigen, we assessed anti-VAR2CSA IgG subclass responses of a cohort of pregnant Beninese, and analyzed their relationships with pregnancy outcomes. Cytophilic IgG1 and IgG3 responses were the most frequent, with prevalences ranging from 28% (IgG3) up to 50% (IgG1). Elevated levels of VAR2CSA-specific total IgG and cytophilic IgG3 during pregnancy were consistently associated with higher birth weights, whilst high levels of IgG4 were associated with a reduced risk of placental infections. This suggests that protective anti-VAR2CSA IgG responses are coordinated between both cytophilic and non-cytophilic antibodies.</abstract>
      <custom6>050 ; 052</custom6>
      <custom1>UR261</custom1>
      <custom7>Bénin / Ghana</custom7>
    </record>
  </records>
</xml>
